Hodnocení stability nových potenciálních léčiv v biologickém materiálu

High performance liquid chromatography (HPLC) is one of the most frequently used analytical techniques for the analysis of drugs. Pyridoxal isonicotinoyl hydrazone (PIH) is a parental compound of the new group of the selective iron chelators derived from aroylhydrazone, which are currently intensive...

Full description

Bibliographic Details
Main Author: Bechná, Lenka
Other Authors: Kovaříková, Petra
Format: Dissertation
Language:Czech
Published: 2008
Online Access:http://www.nusl.cz/ntk/nusl-292568
id ndltd-nusl.cz-oai-invenio.nusl.cz-292568
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-2925682017-09-02T04:15:55Z Hodnocení stability nových potenciálních léčiv v biologickém materiálu Investigation of the stability of novel drug candidates in biological materials Bechná, Lenka Kovaříková, Petra Pilařová, Pavla High performance liquid chromatography (HPLC) is one of the most frequently used analytical techniques for the analysis of drugs. Pyridoxal isonicotinoyl hydrazone (PIH) is a parental compound of the new group of the selective iron chelators derived from aroylhydrazone, which are currently intensively investigated as promising drug candidates. Besides the ability to bind iron, PIH was shown to posses other pharmacological effects: cardioprotective, antioxidative and cytoprotective. This work deals with the investigation of the stability of water-soluble salt of PIH (PIH·2HCl) in three biological materials (rabbit plasma, BSA solution and ultrafiltrate) using HPLC. The half-lives of PIH in these media were calculated as well. The measurement was executed with the guard column Lichrocart - 4×4 mm I.D. (Purospher RP-18C, 5 µm) and the analytical column Lichrocart - 250×4 mm I.D. (Lichrospher 100, RP-18 C, 5 µm). The mobile phase was composed of methanol/acetonitrile (in the ratio 24:14) and phosphate buffer (NaH2PO4 0,01mol/l; pH 6,0 - adjusted by 10% solution NaOH) + EDTA (1,0 mmol/l), in the ratio 50:50. Flow rate was 1 ml/min. The detection was executed in the ultraviolet spectrum at the wavelength of 297 nm. The stability of the PIH was characterized by its half-lives in plasma - t 1/2 = 29 min., BSA... 2008 info:eu-repo/semantics/masterThesis http://www.nusl.cz/ntk/nusl-292568 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Dissertation
sources NDLTD
description High performance liquid chromatography (HPLC) is one of the most frequently used analytical techniques for the analysis of drugs. Pyridoxal isonicotinoyl hydrazone (PIH) is a parental compound of the new group of the selective iron chelators derived from aroylhydrazone, which are currently intensively investigated as promising drug candidates. Besides the ability to bind iron, PIH was shown to posses other pharmacological effects: cardioprotective, antioxidative and cytoprotective. This work deals with the investigation of the stability of water-soluble salt of PIH (PIH·2HCl) in three biological materials (rabbit plasma, BSA solution and ultrafiltrate) using HPLC. The half-lives of PIH in these media were calculated as well. The measurement was executed with the guard column Lichrocart - 4×4 mm I.D. (Purospher RP-18C, 5 µm) and the analytical column Lichrocart - 250×4 mm I.D. (Lichrospher 100, RP-18 C, 5 µm). The mobile phase was composed of methanol/acetonitrile (in the ratio 24:14) and phosphate buffer (NaH2PO4 0,01mol/l; pH 6,0 - adjusted by 10% solution NaOH) + EDTA (1,0 mmol/l), in the ratio 50:50. Flow rate was 1 ml/min. The detection was executed in the ultraviolet spectrum at the wavelength of 297 nm. The stability of the PIH was characterized by its half-lives in plasma - t 1/2 = 29 min., BSA...
author2 Kovaříková, Petra
author_facet Kovaříková, Petra
Bechná, Lenka
author Bechná, Lenka
spellingShingle Bechná, Lenka
Hodnocení stability nových potenciálních léčiv v biologickém materiálu
author_sort Bechná, Lenka
title Hodnocení stability nových potenciálních léčiv v biologickém materiálu
title_short Hodnocení stability nových potenciálních léčiv v biologickém materiálu
title_full Hodnocení stability nových potenciálních léčiv v biologickém materiálu
title_fullStr Hodnocení stability nových potenciálních léčiv v biologickém materiálu
title_full_unstemmed Hodnocení stability nových potenciálních léčiv v biologickém materiálu
title_sort hodnocení stability nových potenciálních léčiv v biologickém materiálu
publishDate 2008
url http://www.nusl.cz/ntk/nusl-292568
work_keys_str_mv AT bechnalenka hodnocenistabilitynovychpotencialnichlecivvbiologickemmaterialu
AT bechnalenka investigationofthestabilityofnoveldrugcandidatesinbiologicalmaterials
_version_ 1718525170263523328